Order results by:
| Issue | Title | |
| Vol 13, No 1 (2017) | THE LINK BETWEEN VITAMIN В12 DEFICIENCY, RISK OF CARDIOVASCULAR DISEASES AND AGING PROCESS | Abstract similar documents |
| O. M. Drapkina, R. N. Shepel | ||
| "... diseases. Usually internists consider that vitamin В12 deficiency is associated with disturbances ..." | ||
| Vol 6, No 3 (2010) | CLINICAL SIGNIFICANCE OF ANEMIC SYNDROME IN PATIENTS WITH CHRONIC HEART FAILURE | Abstract similar documents |
| V. N. Larina, B. Ya. Bart, V. G. Larin | ||
| "... ,041), had diabetes more often (p=0,004, χ2=8,01) in comparison with non anemic patients. Deficiency of iron ..." | ||
| Vol 7, No 5 (2011) | HOMOCYSTEINE-LOWERING THERAPY AND LONG-TERM PROGNOSIS AFTER ELECTIVE PERCUTANEOUS CORONARY INTERVENTION | Abstract similar documents |
| O. O. Shakhmatova, A. L. Komarov, A. N. Samko, T. I. Kotkina, D. V. Rebrikov, A. D. Deev, E. P. Panchenko | ||
| "... B12 deficiency. Aim. To evaluate the effect of FA, B6 and B12 vitamins (in doses approximate ..." | ||
| Vol 16, No 3 (2020) | The Role of Magnesium in the Development of Cardiovascular Diseases and the Possibility of their Prevention and Correction with Magnesium Preparations (Part 2) | Abstract similar documents |
| A. S. Safaryan, V. S. Sargsyan, D. V. Nebieridze | ||
| "... deficiency, and the clinical picture of hypomagnesemia are presented in the article. The necessary daily ..." | ||
| Vol 12, No 2 (2016) | PLEIOTROPIC EFFECTS OF VITAMIN D | Abstract similar documents |
| O. M. Drapkina, R. N. Shepel | ||
| "... Review of clinical studies showing the pleiotropic effect of vitamin D with a detailed description ..." | ||
| Vol 15, No 5 (2019) | The Role of Magnesium in the Development of Cardiovascular Diseases and the Possibility of their Prevention and Correction with Magnesium Preparations (Part 1) | Abstract similar documents |
| A. S. Safaryan, V. S. Sargsyan, T. V. Kamyshova, N. M. Akhmedzhanov, D. V. Nebieridze, E. A. Poddubskaya | ||
| "... of the cardiovascular system. These studies show how magnesium deficiency increases the risk of cardiovascular diseases ..." | ||
| Vol 6, No 5 (2010) | POTASSIUM AND MAGNESIUM DRUGS IN THE TREATMENT OF CARDIOVASCULAR DISEASES IN THE PRACTICE OF PRIMARY CARE PHYSICIAN | Abstract similar documents |
| A. M. Shilov, M. V. Melnik, A. O. Osiya, A. S. Lishuta | ||
| "... Role of magnesium and potassium deficiency in the development of cardiovascular diseases ..." | ||
| Vol 7, No 4 (2011) | FOCUS ON MAGNESIUM BASED DRUGS | Abstract similar documents |
| I. I. Esenova | ||
| "... Magnesium deficiency in the organism is one of the most common human deficiency states ..." | ||
| Vol 10, No 1 (2014) | MAGNESIUM DEFICIENCY AND CARDIOVASCULAR DISEASES: TIME TO ACT | Abstract similar documents |
| E. I. Trisvetova | ||
| "... Progression of cardiovascular disease is often caused by a deficiency of magnesium in the human ..." | ||
| Vol 13, No 5 (2017) | IRON DEFICIENCY AND ANEMIA IN PATIENTS WITH CHRONIC HEART FAILURE | Abstract similar documents |
| N. I. Stuklov | ||
| "... Problems of iron deficiency and anemia in chronic heart failure (CHF) are discussed in the article ..." | ||
| Vol 8, No 4 (2012) | MAGNESIUM IN CLINICAL PRACTICE | Abstract similar documents |
| E. L. Trisvetova | ||
| "... Magnesium is a macronutrient that is needed for normal body functions. Magnesium deficiency ..." | ||
| Vol 16, No 4 (2020) | Real-Life International Normalized Ratio Profile in Patients with Non-Valvular Atrial Fibrillation Prescribed Vitamin K Antagonist | Abstract PDF (Eng) similar documents |
| S. I. Farag, O. S. Arafa, A.A. E. Hassan, H. M. Mashhour, A. M. Bendary | ||
| "... Coagulation status with vitamin K antagonists (VKAs) needs to be monitored carefully to ensure ..." | ||
| Vol 2, No 3 (2006) | EFFICACY OF THERAPY WITH INDIRECT ANTICOAGULANTS: ROLE OF THE FOODSTUFF VITAMIN K CONTENTS | Abstract similar documents |
| A. P. Momot, O. V. Bespalova, E. N. Vorobyova | ||
| "... and acquired (secondary) thrombophilie. The contents of vitamin К1 in nutrition depend on a method of product ..." | ||
| Vol 5, No 1 (2009) | CLINICAL EFFECT OF TESTOSTERONE IN MEN WITH STABLE ANGINA | Abstract similar documents |
| A. Ya. Kravchenko, V. M. Provotorov | ||
| "... and androgen deficiency. Material and methods. The serum testosterone level was detected in 247 men (aged 51 ..." | ||
| Vol 11, No 2 (2015) | ANTICOAGULANT THERAPY IN EVERYDAY CLINICAL PRACTICE: DATA OF THE RETROSPECTIVE CROSS-SECTIONAL STUDY | Abstract PDF (Eng) similar documents |
| V. A. Sulimov, D. A. Napalkov, A. A. Sokolova, A. V. Jilenko, O. S. Anikina | ||
| "... %) was revealed in 79%. 8.45% of the vitamin K antagonist treated patients developed hemorrhagic complications. 16 ..." | ||
| Vol 21, No 2 (2025) | Replenishment of intracellular magnesium deficiency in cardiac arrhythmias: focus on the physicochemical properties of complex compounds | Abstract similar documents |
| Ya. G. Bozhko, N. A. Belokonova, O. M. Medvedeva, K. A. Butova, M. V. Arkhipov | ||
| "... deficiency by eveluating the physicochemical properties of magnesium complex compounds and conducting ..." | ||
| Vol 12, No 1 (2016) | Effect of magnesium on the cardiovascular system in women | Abstract PDF (Eng) similar documents |
| E. A. Ulubieva, A. G. Avtandilov | ||
| Vol 6, No 4 (2010) | MAGNESIUM METABOLISM AND CLINICAL CHARACTERISTICS OF PATIENTS WITH CHRONIC ISCHEMIC HEART DISEASE | Abstract similar documents |
| A. V. Yezhov, L. T. Pimenov, M. A. Makarova, T. V. Savelyev | ||
| "... prevalence of systemic magnesium deficiency (17.9 and 37.5% according to serum and erythrocyte levels ..." | ||
| Vol 8, No 1 (2012) | PHARMACOECONOMIC EVALUATION OF DABIGATRAN VS WARFARIN IN CARDIOVASCULAR EVENTS PREVENTION IN PATIENTS WITH NON-VALVULAR ATRIAL FIBRILLATION | Abstract similar documents |
| Yu. B. Belousov, V. Yu. Mareev, I. S. Yavelov, D. Yu. Belousov | ||
| Vol 14, No 4 (2018) | Risk Controlling of Gastrointestinal Bleeding in Comorbid Patients with Cardiovascular Diseases | Abstract similar documents |
| O. Yu. Chizhova, L. N. Belousova, I. G. Bakulin | ||
| "... with atrial fibrillation (AF) are of leading importance. Recently, non-vitamin K antagonist oral ..." | ||
| Vol 18, No 6 (2022) | Left Ventricular Thrombosis: Current Perspective and Use of Direct Oral Anticoagulants | Abstract similar documents |
| A. D. Aga, A. A. Sokolova, D. A. Napalkov | ||
| "... to clinical guidelines vitamin K antagonists (VKAs) should be used as treatment of choice for thrombus ..." | ||
| Vol 15, No 4 (2019) | According to the AUGUSTUS Trial Apixaban (Eliquis ® ) was Found to Be Safer than Vitamin K Antagonists in Patients with Non-Valvular Atrial Fibrillation with Acute Coronary Syndrome and/or Percutaneous Coronary Intervention | Abstract similar documents |
| Company Pfizer | ||
| Vol 7, No 4 (2011) | EFFECT OF FERROTHERAPY ON COURSE OF ISCHEMIC HEART DISEASE ASSOCIATED WITH MILD IRON DEFICIENCY IN MEN | Abstract similar documents |
| N. S. Belousova, L. V. Frolova, G. E. Chernogoryuk, L. I. Tyukalova | ||
| "... with mild iron deficiency anemia (IDA) and latent iron deficiency (ID). Material and methods. 80 male ..." | ||
| Vol 10, No 4 (2014) | NEW ORAL ANTICOAGULANTS: FOCUS ON THE SAFETY | Abstract similar documents |
| D. A. Napalkov, A. A. Sokolova | ||
| "... Comparative analysis of oral anticoagulants (vitamin K antagonists and new drugs, including ..." | ||
| Vol 21, No 1 (2025) | Correction of anemia using an iron supplement with a hepcidin-independent absorption mechanism in patients with chronic heart failure with preserved left ventricular ejection fraction | Abstract similar documents |
| A. A. Gurkina, N. I. Stuklov, V. A. Kokorin, R. R. Gimadiev, N. V. Varekha | ||
| "... and the development of iron deficiency. Hemoglobin levelincreased from 115 (98-117) g/L to 120 (103-133) g/L, p = 0 ..." | ||
| Vol 12, No 5 (2016) | Features of Modern Anticoagulant Therapy in Patients with Nonvalvular Atrial Fibrillation and Chronic Kidney Disease | Abstract similar documents |
| I. S. Daabul, A. A. Sokolova, D. A. Napalkov | ||
| "... anticoagulant therapy in such situation. Many years the vitamin K antagonists were the only representatives ..." | ||
| Vol 13, No 5 (2017) | ADHERENCE TO THE USE OF NEW ORAL ANTICOAGULANTS IN PATIENTS WITH ATRIAL FIBRILLATION – THE WAY TO SOLVE THE PROBLEM OF EFFICACY AND SAFETY OF TREATMENT | Abstract similar documents |
| S. G. Kanorskii | ||
| "... of anticoagulant therapy include vitamin K antagonists, such as warfarin, whose benefits are long established ..." | ||
| Vol 15, No 6 (2019) | Safety of Non-Vitamin K Oral Anticoagulants in Elderly Patients with Atrial Fibrillation | Abstract similar documents |
| M. A. Gabitova, P. M. Krupenin, A. A. Sokolova, D. A. Napalkov, V. V. Fomin | ||
| "... Aim. To study the safety of non-vitamin K oral anticoagulants (NOAC) in patients with atrial ..." | ||
| Vol 9, No 5 (2013) | PRACTICAL APPLICATION OF DABIGATRAN ETEXILATE FOR STROKE PREVENTION IN PATIENTS WITH ATRIAL FIBRILLATION | Abstract similar documents |
| E. D. Kosmacheva, S. G. Kanorskiy, A. A. Kastanayan, N. V. Haylo, D. B. Goltyapin, E. A. Lipnitskaya, M. E. Statsenko | ||
| "... Disadvantages of vitamin K antagonist warfarin and the benefits of new anticoagulants, including ..." | ||
| Vol 8, No 3 (2012) | COMPARATIVE EFFECTIVENESS PIPOFEZINE, TIANEPTINE AND CHLORPROTHIXENE IN PATIENTS WITH ATTENTION DEFICIT DISORDER , AND HYPERTENSION: AN OPEN NON-RANDOMIZED STUDY | Abstract similar documents |
| V. V. Glushchenko | ||
| "... показатели у пациентов с синдромом дефицита внимания с гиперактивностью (СДВГ) и артериальной гипертензией ..." | ||
| Vol 13, No 5 (2017) | Drug interactions of non-vitamin K antagonist oral anticoagulants: inside and outside table cells | Abstract similar documents |
| Sergey Nikolaevich Bel'diev, Irina Vladimirovna Medvedeva, Dmitry Jur'evich Platonov | ||
| "... profile of drug interaction in comparison to other non-vitamin K antagonist oral anticoagulants (NOAC ..." | ||
| Vol 11, No 1 (2015) | PHARMACOECONOMIC ASPECTS OF APIXABAN FOR PREVENTION OF THROMBOEMBOLIC EVENTS IN PATIENTS WITH ATRIAL FIBRILLATION | Abstract similar documents |
| A. V. Rudakova | ||
| "... ) the following types of antithrombotic therapy are used: anticoagulant therapy with vitamin K antagonists ..." | ||
| Vol 18, No 5 (2022) | Thrombocytopenia Induced by Direct Oral Anticoagulants: a Clinical Case and Literature Review | Abstract similar documents |
| B. A. Tatarsky, N. V. Kazennova | ||
| "... with atrial fibrillation. Direct oral anticoagulants have replaced vitamin K antagonists: either direct ..." | ||
| Vol 6, No 5 (2010) | MAGNESIUM AND MITRAL VALVE PROLAPSE. EFFICACY AND THE POINTS OF APPLICATION | Abstract similar documents |
| A. G. Avtandilov, K. M. Dzeranova, A. A. Pukhaeva, E. D. Manizer | ||
| "... manifestation, despite of the involvement of other organs and systems. Micronutrient deficiencies, especially ..." | ||
| Vol 7, No 3 (2011) | COGNITIVE-MNESTIC FUNCTIONS IN ABLE-BODIED AGED PATIENTS WITH ESSENTIAL ARTERIAL HYPERTENSION IN AMLODIPINE TREATMENT | Abstract similar documents |
| N. N. Ilov, R. N. Shvarts, T. N. Panova | ||
| "... . Cognitive deficiency grade correlated positively with BP elevation degree: a total MMSE score is higher ..." | ||
| Vol 16, No 1 (2020) | Decrease in Efficacy of Warfarin as a Result of Drug-Drug Interaction (Case Report) | Abstract similar documents |
| N. T. Vatutin, G. G. Taradin, G. A. Ignatenko, E. S. Gasendich, A. V. Harchenko, I. B. Povaljaeva | ||
| "... , activated charcoal) could impair the absorption of warfarin, increase intestinal absorption of vitamin K ..." | ||
| Vol 16, No 6 (2020) | The Oral Anticoagulants Administration in Elderly Patients with Geriatric Syndromes: What's New? | Abstract similar documents |
| N. M. Vorobyeva, O. N. Tkacheva | ||
| "... , rivaroxaban, apixaban, and edoxaban) over the vitamin K antagonist warfarin in elderly patients with geriatric ..." | ||
| Vol 17, No 5 (2021) | Gastrointestinal Bleeding: a Cardiologist's Point of View | Abstract similar documents |
| O. V. Averkov, L. N. Mishchenko | ||
| "... , in the early postoperative period after orthopedic surgery. Nowadays it is possible to use vitamin K ..." | ||
| Vol 15, No 4 (2019) | The Therapy with Oral Anticoagulants in Patients with Atrial Fibrillation in Outpatient and Hospital Settings (Data from RECVASA Registries) | Abstract similar documents |
| M. M. Loukianov, S. Yu. Martsevich, O. M. Drapkina, S. S. Yakushin, A. N. Vorobyev, K. G. Pereverzeva, A. V. Zagrebelnyy, V. Val. Yakusevich, V. Vl. Yakusevich, E. M. Pozdnyakova, T. A. Gomova, E. E. Fedotova, M. N Valiakhmetov, V. P. Mikhin, Yu. V. Maslennikova, E. Y. Andreenko, V. G. Klyashtorny, E. V. Kudryashov, E. Yu. Okshina, M. A. Panagopulu, S. A. Boytsov | ||
| "... -vitamin K antagonist oral anticoagulants (NOAC) – 518 (16%). Patients with permanent and persistant types ..." | ||
| Vol 16, No 3 (2020) | Clinical and Pathophysiological Aspects of the Effect of Anticoagulants on Bone Tissue | Abstract similar documents |
| O. D. Ostroumova, I. V. Goloborodova | ||
| "... the effects of unfractionated heparin, low molecular weight heparins, vitamin K antagonists, oral ..." | ||
| Vol 3, No 1 (2007) | CHRONIC HEART FAILURE AND IRON-DEFICIENT ANEMIA | Abstract similar documents |
| M. V. Melnik, A. M. Shilov, I. R. Kim, O. N. Retivykh, A. A. Saricheva | ||
| "... ) was accompanied with the correction of iron deficiency by intravenous injection of Venofer and subsequent Ferro ..." | ||
| Vol 20, No 2 (2024) | Metabolic reprogramming as the basis for sodium-glucose co-transporter type 2 inhibitors cardio- and nephroprotective effect | Abstract similar documents |
| O N. Kurochkina, D. A. Korotkov, A. S. Sazhina, A N. Bogomolov | ||
| "... suppresses the nutrient deficiency sensors SIRT1, AMPK and PGC-1α, which is accompanied by mitochondrial ..." | ||
| Vol 12, No 4 (2016) | Clinical significance of new oral anticoagulants in the prevention of thromboembolic complications in patients with atrial fibrillation: not all dreams come true | Abstract similar documents |
| Yu. A. Bunin, S. V. Miklishanskaya | ||
| "... of them oral anticoagulants were used mainly from the group of vitamin K antagonists, most often warfarin ..." | ||
| Vol 15, No 5 (2019) | Rivaroxaban-Associated Hepatotoxicity: a Clinical Case and Literature Review | Abstract similar documents |
| B. A. Tatarsky, N. V. Kazennova, D. A. Napalkov | ||
| "... Direct oral anticoagulants (not vitamin K antagonists), unlike standard oral anticoagulants (e ..." | ||
| Vol 15, No 5 (2019) | Anticoagulant Therapy as a Tool for the Prevention of Cognitive Impairment Associated with Atrial Fibrillation | Abstract similar documents |
| O. D. Ostroumova, A. I. Kochetkov, S. P. Korchagina, T. M. Ostroumova, M. S. Chernyaeva, A. A. Kirichenko | ||
| "... have been shown that the use of DOACs, as compared to vitamin K antagonists, is a more rational ..." | ||
| Vol 18, No 5 (2022) | Insulin-like Growth Factor-1 and Myocardial Remodeling in Patients with Chronic Heart Failure of Ischemic Origin | Abstract similar documents |
| A. N. Zakirova, N. E. Zakirova, D. F. Nizamova | ||
| "... -normal level, with class IV CHF was established a deficiency of IGF-1. The most significant structural ..." | ||
| Vol 10, No 3 (2014) | COST-EFFECTIVENESS OF APIXABAN AS COMPARED WITH WARFARIN AND ACETYLSALICYLIC ACID IN PATIENTS WITH NON-VALVULAR ATRIAL FIBRILLATION IN THE RUSSIAN FEDERATION | Abstract similar documents |
| A. V. Rudakova, V. A. Parfenov | ||
| "... fibrillation (NVAF) the following types of antithrombotic therapy are used: anticoagulant therapy with vitamin ..." | ||
| Vol 12, No 5 (2016) | Dabigatran Etexilate in the course of Electrical Cardioversion in Patients with Non-Valvular Atrial Fibrillation | Abstract similar documents |
| N. A. Novikova, A. N. Volovchenko | ||
| "... cardioversion. Vitamin K antagonists (warfarin) more often used to prepare for electrical cardioversion. However ..." | ||
| Vol 16, No 2 (2020) | The Current Status of Direct Oral Anticoagulants in Cancer-Related Venous Thromboembolism Treatment | Abstract similar documents |
| К. V. Lobastov, I. V. Schastlivtsev | ||
| "... of cancer-related venous thrombosis should be at least 6 months. The use of vitamin K antagonists (VKA ..." | ||
| Vol 17, No 1 (2021) | Basic Aspects of Seasonal Cardiovascular Mortality | Abstract similar documents |
| G. F. Andreeva, V. M. Gorbunov | ||
| "... the dynamics of cardiovascular mortality during the year: seasonal fluctuations in the level of vitamin D ..." | ||
| Vol 15, No 1 (2019) | Comparative Analysis of Antithrombotic Therapy in In-Patients with Atrial Fibrillation | Abstract similar documents |
| V. I. Petrov, O. V. Shatalova, A. S. Gerasimenko, V. S. Gorbatenko | ||
| "... ) in 2016. A significant number of patients in this group received anticoagulant therapy with vitamin K ..." | ||
| Vol 19, No 5 (2023) | Daily breakfast: will skipping a morning meal become a new prognostic marker? | Abstract similar documents |
| O. B. Shvabskaia, N. S. Karamnova, O. M. Drapkina | ||
| "... , the nutritional value of consumption of total protein, vitamins and minerals, as well as the uniform meal ..." | ||
| Vol 6, No 1 (2010) | PECULIARITIES OF PURINE METABOLISM AND LIPID PEROXIDATION IN PATIENTS WITH ACUTE MYOCARDIAL INFARCTION | Abstract similar documents |
| E. V. Horolets, L. A. Haisheva, S. V. Shlyk, L. I. Katelnitskaya | ||
| "... increases, antioxidant and prooxidant balance disturbs at the condition of energy deficiency. AHF ..." | ||
| Vol 17, No 4 (2021) | Antithrombotic Management for Patients with Atrial Fibrillation Undergoing Percutaneous Coronary Intervention | Abstract similar documents |
| A. V. Panov | ||
| "... inhibitors and direct oral anticoagulant (DOAC) instead of vitamin K antagonists. The primary choice of DOAC ..." | ||
| Vol 17, No 3 (2021) | Intestinal Microbial-tissue Complex and Chronic Heart Failure (part 1): Pathogenesis | Abstract similar documents |
| A. A. Vlasov, S. P. Salikova, N. V. Golovkin, V. B. Grinevich | ||
| "... . Besides, a decrease in the production of short-chain and polyunsaturated fatty acids and vitamins ..." | ||
| Vol 14, No 3 (2018) | APPROACHES TO THE CHOICE OF ANTICOAGULANT THERAPY IN THE TREATMENT OF PATIENTS WITH COMBINATION OF ATRIAL FIBRILLATION WITH CORONARY HEART DISEASE OR PERIPHERAL ATHEROSCLEROSIS: POTENTIAL OF APIXABAN | Abstract similar documents |
| O. D. Ostroumova, A. I. Kochetkov, I. Yu. Orlova, E. A. Smolyarchuk, J. S. Pavlova | ||
| "... oral anticoagulants (NOAC) instead of vitamin K antagonists (eg, warfarin), low doses of NOAC, studied ..." | ||
| Vol 17, No 1 (2021) | Pharmacokinetics and Pharmacogenetics of Dabigatran | Abstract similar documents |
| A. V. Savinova, V. S. Dobrodeeva, M. M. Petrova, R. F. Nasyrova, N. A. Shnayder | ||
| "... . Pharmacokinetics of dabigatran etexilate doesn’t have the disadvantages of vitamin K antagonists. However ..." | ||
| Vol 15, No 4 (2019) | Optimization of Pharmacotherapy with Direct Oral Anticoagulants: the Need to Choose the Right Dosage Regimen | Abstract similar documents |
| A. I. Kochetkov, O. D. Ostroumova | ||
| "... of direct oral anticoagulants (DOACs) compared with vitamin K antagonists due to the extensive body ..." | ||
| Vol 16, No 1 (2020) | Levocarnitine for the Treatment of Polymorbid Patients | Abstract similar documents |
| A. P. Pereverzev, D. A. Shevchenko, A. V. Filippova, A. A. Kirichenko, I. F. Krotkova, O. D. Ostroumova | ||
| "... and impaired reabsorption, a deficiency of levocarnitine in the body tissues develops, and therefore the US ..." | ||
| Vol 3, No 2 (2007) | IMMUNO-INFLAMATORY RESPONSE IN ISCHEMIC HEART DISEASE | Abstract similar documents |
| N. E. Zakirova, N. Kh. Khafizova, I. M. Karamova, A. N. Zakirova, R. G. Oganov | ||
| "... -inflammatory cytokines and deficiency of anti-inflammatory cytokines. ..." | ||
| Vol 17, No 1 (2021) | Cardiomyopathy of Friedreich's Disease. Modern Methods of Diagnostic | Abstract PDF (Eng) similar documents |
| E. I. Fomicheva, R. P. Myasnikov, Y. A. Selivyorstov, S. N. Illarioshkin, E. L. Dadali, O. M. Drapkina | ||
| "... 's disease is mitochondrial ataxia, caused by a deficiency in the transcription of the FXN gene, leading ..." | ||
| Vol 20, No 5 (2024) | Effectiveness and safety of direct oral anticoagulants in patients with atrial fibrillation and chronic kidney disease: a systematic review and meta-analysis of clinical trials | Abstract similar documents |
| E. M. Mezhonov, Z. M. Safiullina, Y. A. Vyalkina, S. V. Shalaev | ||
| "... 4 or 5 chronic kidney disease" or "stage 5 chronic kidney disease" and "non-vitamin K antagonist ..." | ||
| Vol 11, No 3 (2015) | ANALYSIS OF THE INFLUENCE OF THROMBOEMBOLIC COMPLICATIONS PREVENTION WITH ORAL ANTICOAGULANTS ON BUDGET IN PATIENTS WITH NON-VALVULAR ATRIAL FIBRILLATION | Abstract similar documents |
| A. V. Rudakova | ||
| "... administration of vitamin K antagonists (warfarin) or the new oral anticoagulants (apixaban, dabigatran ..." | ||
| Vol 16, No 2 (2020) | Risk Factors, Clinical Features of the Course of Myocardial Infarction and Treatment of Young Patients Based on Two Hospital Registries | Abstract similar documents |
| O. L. Barbarash, D. Yu. Sedykh, I. S. Bykova, V. V. Kashtalap, A. D. Erlich | ||
| "... , deficiency of high density lipoproteins (p=0.005) was more often found in the absence of very high values ..." | ||
| Vol 6, No 5 (2010) | THE INVASIVE DENTAL PROCEDURES IN PATIENTS TREATING WITH WARFARIN: POSSIBILITIES AND PROSPECTS FOR SAFETY | Abstract similar documents |
| T. V. Kozlova, I. M. Makeyeva, V. Y. Doroshina, S. I. Bokareva | ||
| "... Details of the management of patients receiving oral anticoagulants (vitamin K antagonists ..." | ||
| Vol 10, No 2 (2014) | SECONDARY PREVENTION OF STROKE IN PATIENTS WITH NON-VALVULAR ATRIAL FIBRILLATION: THE CLINICIANS’ VIEWPOINT | Abstract similar documents |
| E. A. Drozdova | ||
| "... терапии антагонистом витамина К варфарином и прямым ингибитором тромбина дабигатраном. ..." | ||
| Vol 11, No 2 (2015) | MORPHOFUNCTIONAL CHARACTERISTICS OF FIBROBLASTS (MCCOY CELL LINE) CULTURED WITH MAGNESIUM PREPARATIONS | Abstract similar documents |
| L. V. Didenko, T. G. Borovaya, E. A. Kost, E. A. Ulubieva, A. V. Timofeeva, A. G. Avtandilov | ||
| "... магния, а также магния в комбинации с витамином В6 возникали выраженные изменения морфофункционального ..." | ||
| Vol 7, No 5 (2011) | EFFECT OF ERYTHROPOIETIN ON THE CLINICAL COURSE OF CHRONIC HEART FAILURE IN PATIENTS WITH ANEMIA: RESULTS OF NOT COMPARATIVE STUDY | Abstract similar documents |
| V. M. Provotorov, S. A. Avdeeva | ||
| "... into the study. They received basic CHF therapy. Patients (n=12) with iron deficiency anemia also received ..." | ||
| Vol 1, No 1 (2005) | MENOPAUSE AND CARDIOVASCULAR RISK | Abstract similar documents |
| D. A. Anichkov, N. A. Shostak, A. D. Zhuravleva | ||
| "... дефицита эстрогенов на артериальную стенку. Коррекция факторов риска у женщин в постменопаузе должна ..." | ||
| Vol 15, No 2 (2019) | Studies of Anticoagulant Therapy in Frail Elderly Patients: Problems of Terminology and Methodology | Abstract similar documents |
| S. N. Bel'diev, I. V. Medvedeva, D. Yu. Platonov, G. Yu. Trufanova | ||
| "... with frailty syndrome contains two statements which highlight ri-varoxaban among other non-vitamin K antagonist ..." | ||
| Vol 15, No 2 (2019) | Studies of Anticoagulant Therapy in Frail Elderly Patients: Problems of Terminology and Methodology | Abstract similar documents |
| Sergey N. Bel'diev, Irina V. Medvedeva, Dmitry Yu. Platonov, Galina Yu. Trufanova | ||
| "... rivaroxaban among other non-vitamin K antagonist oral anticoagulants (NOAC): 1) none of the randomized ..." | ||
| Vol 13, No 3 (2017) | HYPERTHYROIDISM AND ATRIAL FIBRILLATION | Abstract similar documents |
| I. M. Marusenko, E. G. Petrova | ||
| "... of iodine deficiency; it is relevant for our country due to the large territory of iodine deficiency ..." | ||
| Vol 13, No 4 (2017) | THE PROBLEM OF ADHERENCE TO THE TREATMENT IN MODERN MEDICINE: POSSIBILITIES OF SOLUTION, IMPACT ON THE EFFECTIVENESS OF THERAPY AND DISEASE OUTCOMES | Abstract similar documents |
| Yu. V. Lukina, N. P. Kutishenko, S. Yu. Martsevich | ||
| "... значимых прорывов в данном направлении: (1) нерешенные вопросы с терминологией, особенно дефицит ..." | ||
| Vol 18, No 1 (2022) | Three Year Prognosis of Patients with Myocardial Infarction Depending on the Body Weight Index: Data of the Kemerovo Acute Coronary Syndrome Registry | Abstract PDF (Eng) similar documents |
| D. Yu. Sedykh, A. I. German, O. N. Hryachkova, V. V. Kashtalap, O. L. Barbarash | ||
| "... ,3%); II – у 67 (7,7%); III – у 20 (2,3%)], дефицит массы тела у 4 (0,5%), нормальная масса тела у 179 (20 ..." | ||
| Vol 17, No 2 (2021) | Anticoagulant Therapy in Patients with Non-valvular Atrial Fibrillation in Real Clinical Practice: in Appropriate Dose Reductions | Abstract similar documents |
| V. A. Ionin, O. I. Bliznuk, E. I. Baranova, E. V. Shlyakhto | ||
| "... ,3%) patients received vitamin K antagonist (warfarin). The international normalized ratio in the target range ..." | ||
| Vol 12, No 6 (2016) | Efficacy and safety of the new oral anticoagulants in the treatment of venous thromboembolic complications: meta-analysis | Abstract PDF (Eng) similar documents |
| V. I. Petrov, O. V. Shatalova, V. S. Gorbatenko, O. N. Smuseva, A. S. Maslakov | ||
| "... as vitamin K antagonists (VKAs) in preventing recurrent symptomatic VTE (RR=0.93; 95% CI 0.77-1.12; p=0 ..." | ||
| Vol 12, No 1 (2016) | Efficacy and safety of the new oral anticoagulants in the treatment of venous thromboembolic complications: meta-analysis | Abstract similar documents |
| V. I. Petrov, O. V. Shatalova, V. S. Gorbatenko, O. N. Smuseva, A. S. Maslakov | ||
| "... as vitamin K antagonists (VKAs) in preventing recurrent symptomatic VTE (RR=0.93; 95% CI 0.77-1.12; p=0 ..." | ||
| Vol 9, No 4 (2013) | EFFECT OF IRON AND SELENIUM DRUGS ON DIASTOLIC MYOCARDIAL FUNCTION IN PATIENTS WITH ANEMIC CARDIOMYOPATHY | Abstract similar documents |
| E. V. Goncharova, A. V. Govorin | ||
| "... therapy. Material and methods. Patients (n=54) with severe chronic post-hemorrhagic iron deficiency anemia ..." | ||
| Vol 20, No 6 (2024) | An in-depth study of the association of breast arterial calcification with cardiovascular disease, its risk factors, and other chronic noncommunicable diseases: rationale and study protocol | Abstract similar documents |
| I. V. Kim, E. V. Bochkareva, E. K. Butina, O. V. Molchanova, N. Kh. Bayramkulova, E. M. Filichkina, E. B. Yarovaya, O. M. Drapkina | ||
| "... as traditional risk factors for cardiovascular diseases. The relationship of BAC with iron deficiency anemia ..." | ||
| Vol 16, No 1 (2020) | Control Of Anticoagulation Therapy in Atrial Fibrillation (COAT-AF Study) in Real Clinical Practice | Abstract similar documents |
| A. A. Zarudsky, A. A. Gavrilova, Т. S. Filinichenko | ||
| "... терапии. При поступлении в стационар 60 (14%) больных получали оральные не-антагонисты витамина К (НОАК ..." | ||
| Vol 7, No 1 (2011) | ANTIARRHYTHMIC EFFICACY OF PROPAFENONE IN PATIENTS WITH PERSISTENT ATRIAL FIBRILLATION | Abstract similar documents |
| R. D. Kurbanov, N. U. Zakirov, Sh. K. Azizov | ||
| "... , и исходный дефицит пульса 24,6±15,0 против 13,56±5,7 ударов в мин (р<0,05), соответственно. На фоне ..." | ||
| Vol 14, No 3 (2018) | ECONOMIC BURDEN OF HYPERCHOLESTEROLEMIA IN THE RUSSIAN FEDERATION | Abstract similar documents |
| A. V. Kontsevaya, Yu. A. Balanova, A. E. Imaeva, M. B. Khudyakov, O. I. Karpov, O. M. Drapkina | ||
| "... , as well as the deficiency of the gross domestic product (GDP). Aim. Evaluation of economic impact due ..." | ||
| Vol 12, No 6 (2016) | ANNUAL FORECAST IN PATIENTS WITH ACUTE ISCHEMIC STROKE: ROLE OF PATHOLOGICAL ANKLE-BRACHIAL INDEX | Abstract similar documents |
| A. N. Sumin, J. A. Kolmykova, I. N. Kukhareva, M. V. Ott, N. I. Vodopyanova, A. A. Morkvenas, O. A. Trubnikova, A. V. Kovalenko | ||
| "... атеросклероза, избыточная масса тела. Пациенты группы 2 исходно имели более грубый неврологический дефицит ..." | ||
| Vol 9, No 4 (2013) | EFFECT OF SIMVASTATIN ON THE PROGNOSIS AND THE CHANGES OF THE CLINICAL STATUS IN PATIENTS WITH ACUTE ISCHEMIC STROKE. THE RESULTS OF THE 12 MONTH RANDOMIZED, OPEN COMPARATIVE STUDY | Abstract similar documents |
| V. V. Yakusevich, A. Yu. Malygin, A. V. Kabanov | ||
| "... , частоту повторных кардиоваскулярных событий, динамику нев- рологического дефицита, эндотелиальной ..." | ||
| Vol 11, No 2 (2015) | AN OUTPATIENT WITH ATRIAL FIBRILLATION: KEY FEATURES. THE FIRST DATA OF REKVAZA FP - YAROSLAVL REGISTER | Abstract similar documents |
| V. V. Yakusevich, E. M. Pozdnyakova, Vl. .V. Yakusevich, V. A. Simonov, S. Yu. Martsevich, M. M. Loukianov, A. V. Zagrebelnyy, S. A. Boytsov | ||
| "... ,7% включенных в регистр пациентов. Заключение: Нерегулярность наблюдения и дефицит обследования больных с ФП ..." | ||
| Vol 10, No 1 (2014) | THE ROLE OF THE MATRIX METALLOPROTEINASES IN THE DEVELOPMENT OF LEFT VENTRICULAR HYPERTROPHY IN PATIENTS WITH ARTERIAL HYPERTENSION AND METABOLIC SYNDROME | Abstract similar documents |
| A. N. Zakirova, E. Z. Fatkullina, N. E. Zakirova | ||
| "... ожирения. Наиболее значимая структурно-геометрическая перестройка ЛЖ и активация ПроММП-1 при дефиците ТИМП ..." | ||
| Vol 11, No 4 (2015) | PILOT STUDY RESULTS OF THE INFLUENCE OF CITICOLINE AND PIRIBEDIL ON COGNITIVE FUNCTION IN PATIENTS WITH ISCHEMIC HEART DISEASE AFTER CORONARY ARTERY BYPASS SURGERY | Abstract similar documents |
| M. M. Petrova, S. V. Prokopenko, O. V. Eremina, G. V. Matjushin, V. A. Sakovich, D. B. Drobot, E. Yu. Mozhejko, D. S. Kaskaeva | ||
| "... Цель. Выявление когнитивного дефицита, развивающегося после операции коронарного шунтирования (КШ ..." | ||
| Vol 11, No 5 (2015) | Insulin-like growth factor-1 and myocardial remodeling in female patients with arterial hypertension and metabolic syndrome | Abstract similar documents |
| A. N. Zakirova, E. R. Fatkullina, N. E. Zakirova, L. M. Zhamalov | ||
| "... показателей ИФР-1 (118,5±10,05 нг/мл). Дефицит ИФР-1 (96,4±8,11 нг/мл) установлен у пациенток с ожирением 3 ..." | ||
| Vol 8, No 1 (2012) | THE EFFICACY OF HIGH-DOSE SIMVASTATIN IN ACUTE PERIOD OF ISCHEMIC STROKE | Abstract similar documents |
| V. V. Yakusevich, A. Yu. Malygin, S. V. Lychenko, A. S. Petrochenko, A. V. Kabanov | ||
| "... , динамику неврологического дефицита и эндотелиальной дисфункции у пациентов с впервые возникшим ишемическим ..." | ||
| Vol 14, No 2 (2018) | SINGLE AND MULTIPLE ISCHEMIC BRAIN MICROLESIONS AFTER CAROTID ARTERY STENTING | Abstract similar documents |
| E. S. Bulgakova, T. V. Tvorogova, В. A. Rudenko, O. М. Drapkina | ||
| "... (35,7% против 13,3%, p<0,05), появлением периоперационного неврологического дефицита (21,4% против 4 ..." | ||
| 1 - 90 of 90 Items | ||
Search tips:
- Search terms are case-insensitive
- Common words are ignored
- By default articles containing any term in the query are returned (i.e., OR is implied)
- Make sure that a word exists in an article by prefixing it with +; e.g., +journal +access scholarly academic
- Combine multiple words with AND to find articles containing all terms; e.g., education AND research
- Exclude a word by prefixing it with - or NOT; e.g., online -politics or online NOT politics
- Search for an exact phrase by putting it in quotes; e.g., "open access publishing". Hint: Quoting Chinese or Japanese words will help you to find exact word matches in mixed-language fields, e.g. "中国".
- Use parentheses to create more complex queries; e.g., archive ((journal AND conference) NOT theses)
